Bessemer Group
PROF

Bessemer Group’s Profound Medical PROF Stock Holding History

Bessemer Group’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-165
Closed -$2K – 1931
2021
Q4 		$2K Hold
165
– – ﹤0.01% 1773
2021
Q3 		$2K Sell
165
-500
-75% -$7.62K ﹤0.01% 1603
2021
Q2 		$11K Sell
665
-800
-55% -$14.9K ﹤0.01% 1332
2021
Q1 		$30K Sell
1,465
-135
-8% -$3.24K ﹤0.01% 1112
2020
Q4 		$33K Sell
1,600
-800
-33% -$14.7K ﹤0.01% 1079
2020
Q3 		$42K Sell
2,400
-800
-25% -$12.7K ﹤0.01% 949
2020
Q2 		$54K Buy
+3,200
New +$40.4K ﹤0.01% 1332

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

Bessemer Group's PROF Position: Q1 2022 in Review

Bessemer Group sold out of Profound Medical (PROF) in Q1 2022, closing a stake of 165 shares — an estimated $2K sold.

Bessemer Group first reported a position in PROF in Q2 2020 and held it in 7 quarters. The position peaked at $54K in Q2 2020. 44 funds tracked by Wall St. Rank hold PROF as of Q1 2022.

  • Bessemer Group reported no remaining Profound Medical position as of Q1 2022 after selling out during the quarter.
  • Bessemer Group sold 165 Profound Medical shares in Q1 2022, an estimated $2K.
  • Bessemer Group first reported a position in Profound Medical in Q2 2020 and held it in 7 quarters.
  • Bessemer Group's Profound Medical position peaked at $54K in Q2 2020.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q1 2022.

Based on Bessemer Group's 13F filing for Q1 2022, filed 12 May 2022.